Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
About Tender
🚂 Urgent Tender For Insulin Cartridges 💉🚫 The Ministry Of Railways, Under The Central Government, Invites Tenders For The Supply Of Monocomponent Biosynthetic R Dna Insulin Solution For Injection In 3 Ml Cartridges For Subcutaneous Use. The Insulin Composition Is 70% Insulin Degludec And 30% Insulin Aspart, With A Total Of 100 Units Per Ml. 📅 Tender Submission Deadline: May 29, 2024, 2:30 Pm This Tender Is For Complete Deionized Water (Di) And All Other Specifications As Detailed In The Tender Document. Interested Bidders Must Submit Their Proposals By The Stipulated Deadline, With No Tender Fee Or Earnest Money Deposit (Emd) Required. Keywords: Insulin Cartridges, Ministry Of Railways, Central Government, Tender, Biosynthetic R Dna Insulin, Insulin Degludec, Insulin Aspart, Subcutaneous Use, Procurement, Medical Supplies| Particulars | Details |
|---|---|
| Title |
Supply Of Srph031229 Monocomponent Biosynthetic R Dna Insulin Solution For Injection In 3 Ml Cartridge For Subcutaneous Use 70 Percent Insulin Degludec/30 Percent Insulin Aspart Penfill 100 Units Per Ml.
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106346867 |
|
Reference Number |
97245528 |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | |
| Place | Chennai |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/052024/106346867/viewNitPdf_4571903.pdf |
| Start Date | May 15, 2024 20:22 |
| End Date |
Expired
29/05/2024
Expired 738 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Srph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read moreSrph031080-human insulin soluble insulin 30 percent and insulin isophane 70 percent 40 iu/ml - 10 ml injection. srph031212-insulin aspart 30 percent and protamine insulin aspart 70 percent suspension 100 i.u / ml, 3 ml cartridge unit:cart. srph031229-monocomponent biosynthetic r-dna insulin solution for injection in 3 ml cartridge for subcutaneous use 70 percent insulin degludec/30 percent insulin aspart penfill 100 units per ml.
For complete deion and other details, please refer to tender
Read more(ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec 30 percent insulin aspart - 100 iu/ml - 3ml
For complete deion and other details, please refer to tender
Read more( ph.no. 31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec 30 percent insulin aspart - 100 iu/ml - 3ml penfil
For complete deion and other details, please refer to tender
Read moreInsulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
Read moreInsulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
Read moreInsulin degludec / insulin aspart (r-dna origin) solution for subcutaneous injection. 1ml of the solution contains 100 units insulin degludec and insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56mg salt-free anhydrous insulin degludec and 1.05mg salt-free anhydrous insulin aspart in 3ml penfill cartridge.
For complete deion and other details, please refer to tender
Read moreof your Industry type